New York Life Investment Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,490
Closed -$325K 1384
2022
Q4
$325K Buy
37,490
+4,222
+13% +$44.5K ﹤0.01% 1109
2022
Q3
$345K Buy
33,268
+2,446
+8% +$32.3K ﹤0.01% 1040
2022
Q2
$405K Buy
+30,822
New +$447K ﹤0.01% 949

Other funds holding SWBI

New York Life Investment Management's SWBI Position: Q1 2023 in Review

New York Life Investment Management sold out of Smith & Wesson (SWBI) in Q1 2023, closing a stake of 37,490 shares — an estimated $325K sold.

New York Life Investment Management first reported a position in SWBI in Q2 2022 and held it in 3 quarters. The position peaked at $405K in Q2 2022. 169 funds tracked by Wall St. Rank hold SWBI as of Q1 2023.

  • New York Life Investment Management reported no remaining Smith & Wesson position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 37,490 Smith & Wesson shares in Q1 2023, an estimated $325K.
  • New York Life Investment Management first reported a position in Smith & Wesson in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Smith & Wesson position peaked at $405K in Q2 2022.
  • 169 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.